UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 10.

Kappos, L; Edan, G; Freedman, M S; Montalbán, X; Hartung, H P; Hemmer, B; Fox, E J; Barkhof, F; Schippling, S; Schulze, A; Pleimes, D; Pohl, C; Sandbrink, R; Suarez, G; Wicklein, E M (2016). The 11-year long-term follow-up study from the randomized BENEFIT CIS trial. Neurology, 87(10):978-987.

Schippling, S; O'Connor, P; Knappertz, V; Pohl, C; Bogumil, T; Suarez, G; Cook, S; Filippi, M; Hartung, H P; Comi, G; Jeffery, D R; Kappos, L; Goodin, D S; Arnason, B (2016). Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial. Journal of Neurology, 263(7):1418-1426.

Jarius, S; Ruprecht, K; Wildemann, B; Kuempfel, T; Ringelstein, M; Geiser, C; Kleiter, I; Kleinschnitz, C; Berthele, A; Brettschneider, J; Hellwig, K; Hemmer, B; Linker, R A; Lauda, F; Mayer, C A; Tumani, H; Melms, A; Trebst, C; Stangel, M; Marziniak, M; Hoffmann, F; Schippling, S; Faiss, J H; Neuhaus, O; Ettrich, B; Zentner, C; Guthke, K; Hofstadt-van Oy, U; Reuss, R; Pellkofer, H; Ziemann, U; Kern, P; Wandinger, K P; Bergh, F; Boettcher, T; Langel, S; Liebetrau, M; Rommer, P S; Niehaus, S; Münch, C; Winkelmann, A; Zettl U, U K; Metz, I; Veauthier, C; Sieb, J P; Wilke, C; Hartung, H P; Aktas, O; Paul, F (2012). Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. Journal of Neuroinflammation, 9:14.

Brandt, A U; Zimmermann, H; Kaufhold, F; Promesberger, J; Schippling, S; Finis, D; Aktas, O; Geiser, C; Ringelstein, M; Ringelstein, E B; Hartung, H P; Paul, F; Kleffner, I; Dörr, J (2012). Patterns of retinal damage facilitate differential diagnosis between Susac syndrome and MS. PLoS ONE, 7(6):e38741.

Oberwahrenbrock, T; Schippling, S; Ringelstein, M; Kaufhold, F; Zimmermann, H; Keser, N; Young, K L; Harmel, J; Hartung, H P; Martin, R; Paul, F; Aktas, O; Brandt, A U (2012). Retinal damage in multiple sclerosis disease subtypes measured by high-resolution optical coherence tomography. Multiple sclerosis international, 2012:530305.

Brandt, A U; Oberwahrenbrock, T; Ringelstein, M; Young, K L; Tiede, M; Hartung, H P; Martin, R; Aktas, O; Paul, F; Schippling, S (2011). Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain: A Journal of Neurology, 134(Pt 11):e193; author reply e194.

Diener, H C; Hartung, H P; Bien, C G; Hacke, W; Ringelstein, E B; Ludolph, A; Deuschl, G; Wiltfang, J; Weller, M; Steinhausen, K; Stemper, B; Klatt, J; Drepper, J; Griewing, B; Meier, U; Herschel, M; Hummel, K; Paar, W D; Dintsios, C M; Schade-Brittinger, C; Weber, R; Weimar, C (2009). Klinische Studien in der Neurologie in Deutschland 2008. Aktuelle Neurologie, 36(1):8-18.

Schreiner, B; Kieseier, B C; Hartung, H P; Hohlfeld, R; Wiendl, H (2005). Blockade von Adhäsionsmolekülen mit Natalizumab in der Therapie der Multiplen Sklerose. Aktueller Studienstand. Der Nervenarzt, 76(8):999-1005.

Mitsdoerffer, M; Schreiner, B; Kieseier, B C; Neuhaus, O; Dichgans, J; Hartung, H P; Weller, M; Wiendl, H (2005). Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis. Journal of Neuroimmunology, 159(1-2):155-164.

Schreiner, B; Mitsdoerffer, M; Kieseier, B C; Chen, L; Hartung, H P; Weller, M; Wiendl, H (2004). Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. Journal of Neuroimmunology, 155(1-2):172-182.

This list was generated on Mon Jul 24 01:00:57 2017 CEST.